JPRN-jRCTs031180259已完成未知
Tolvaptan Intervention study to Autosomal Dominant PolycysticKidney Disease patients without Genetic mutation of disease gene - TIAG
Horie Shigeo0 个研究点目标入组 0 人开始时间: 2019年3月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
Genetic diagnosis in ADPKD has not progressed and there are no registered cases
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •ADPKD patients without genetic mutation of disease gene(PKD1, PKD2)
排除标准
- •ADPKD patients with genetic mutation of disease gene(PKD1,PKD2)
研究者
相似试验
已完成
不适用
10-year tolvaptan in ADPKD - A patient-based center evaluatioQ61.2Polycystic kidney, autosomal dominantDRKS00019856Otsuka Pharma GmbH13
已完成
不适用
Clinical implications of DNA analysis on ADPKDAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000018764ADPKD Research section, Kyorin University, School of Medicine85
已完成
1 期
Phase I/II Study of Gene Therapy for AADC deficiencyAromatic L-amino acid decarboxylase deficiencyJPRN-jRCT2033210641Yamagata Takanori1
尚未招募
2 期
Experimental study to assess the efficacy of Adityapaka Guggulu and Prasaranyadi Kwatha along with Anu taila Pratimarsha Nasya in the management of Greeva Sandhivata with special reference to Cervical Spondylosis.CTRI/2022/11/046954Department of kayachikitsa Faculty of Ayurveda
招募中
不适用
The German ADPKD Tolvaptan Treatment RegistryADPKD (Autosomal Dominant Polycystic Kidney Disease)NCT02497521University of Cologne2,000